Question to the Department of Health and Social Care:

To ask Her Majesty’s Government what measures they are taking to support research into paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour cancer.

The Department's National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including gastrointestinal stromal tumours (GIST). These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and the National Health Service, value for money and scientific quality.

NIHR research infrastructure including NIHR biomedical research centres and the NIHR Clinical Research Network are hosting studies in GIST including a phase I/II study of sunitinib in young patients with advanced GIST.